Renal: Renogram,
 Diuretic, and Captopril:
Tubular Function, ERPF,
        and GFR

                  BY


 DR. ASHRAF ANAS ZYTOON MD, PHD, FJRS
   MENOUFIYA UNIVERSITY - EGYPT
Radiopharmacy
Radionuclide
99mTc

t1/2: 6 hours
Energies: 140 keV
Type: IT, γ, generator


Radiopharmaceutical
• 99mTc-DTPA (diethylenetriaminepentaacetic acid)
• 99mTc-MAG3® (mercaptoacetyltriglycine)
Adult Dose Range
99mTc:3–20 mCi (111–740 MBq) generally 10 mCi
(370 MBq) for most studies.
Method of Administration
• Bolus intravenous injection
• If study includes a diuretic use butterfly or IV
  catheter (furosemide).
• ACE inhibitor study:
 – Captopril (Capoten®) is given PO 1 hour before exam.
 – Enalapril maleate (Vasotec® intravenous over 3–5 minutes).
Indications

• Evaluation for renal artery stenosis, obstruction,
  and/or trauma.

• Evaluation of renal tubular function and perfusion
  (glomerular filtration) for blood flow, parenchyma, and
  excretion.

• Evaluation of renal vascular flow (effective renal
  plasma flow).

• Evaluation of renal obstructive nephropathy and/or
  hydronephrosis (study with furosemide).
Indications

• Evaluation for renal       (renovascular)   hypertension
  (captopril study).

• Evaluation of renovascular hypertension therapy.

• Evaluation of abdominal or flank bruits, azotemia,
  pulmonary edema, retinopathy, and unexplained renal
  dysfunction.

• Detection of acute tubular necrosis.

• Evaluation of a kidney transplant.
Contraindications

• Iodine IV contrast study on same day.

• Patient still on adrenal cortical extract (ACE, or
  angiotensin-converting     enzyme)   inhibitors or
  angiotensin receptor blocker (ARB).

• Food intake too close to a captopril study will decrease
  the sensitivity of the test and slow the absorption of
  the ACE inhibitor.

• Beta blockers may affect production of renin.
Patient Preparation
• Identify the patient. Verify doctor's order. Explain the
  procedure.

• Instruct patient to hydrate well (water) and void just
  before test.

• Physician is to instruct patient to discontinue ACE
  inhibitors for several days (3–7) before examination.

• Instruct patient to be NPO for at least four hours on
  morning before captopril study.

• Post study voiding is recommended to lessen bladder
  exposure.
Equipment

Camera
Large field of view

Collimator
low energy, all purpose, or low energy, high resolution
Normal Results

• Assuming two kidneys, both kidneys visualizing about
  the same size and intensities.

• Excretion at the same rate.

• Smooth renal contour.

• Time-to-peak concentration is 3 to 5 minutes.

• Clearance t1/2 is 12 to 15 minutes.

• GFR (glomerular filtration rate) = 125 mL/minute.
Artifacts

• Some patients do not have both kidneys.

• Injection problems for flow or bad start.

• Infiltration at the injection site can alter renography
  curves, food within 4 hours of study, pelvic retention,
  dehydration, hypotension, or full bladder at the start of
  the study.

• False-positives   of   mechanical    obstruction:   poor
  hydration.
Patient History 1 (The patient should answer the following questions).

• Do you have a history of kidney disease (e.g., stones,
  infections)?

• Do you have both kidneys?

• Are there any recent or planned operations?

• Do you have any renal pain?

• Are you experiencing urinary frequency or urgency?
Patient History 2 (The patient should answer the following questions).
• Do you have any blood in your urine?
• Do you have high blood pressure?
• Do you have the results of any recent renal
  laboratory tests?
• What medications are you currently taking
  (please list)?
• Female: Are you pregnant or nursing?

Nuclear Medicine Procedures-2

  • 1.
    Renal: Renogram, Diuretic,and Captopril: Tubular Function, ERPF, and GFR BY DR. ASHRAF ANAS ZYTOON MD, PHD, FJRS MENOUFIYA UNIVERSITY - EGYPT
  • 2.
    Radiopharmacy Radionuclide 99mTc t1/2: 6 hours Energies:140 keV Type: IT, γ, generator Radiopharmaceutical • 99mTc-DTPA (diethylenetriaminepentaacetic acid) • 99mTc-MAG3® (mercaptoacetyltriglycine)
  • 3.
    Adult Dose Range 99mTc:3–20mCi (111–740 MBq) generally 10 mCi (370 MBq) for most studies. Method of Administration • Bolus intravenous injection • If study includes a diuretic use butterfly or IV catheter (furosemide). • ACE inhibitor study: – Captopril (Capoten®) is given PO 1 hour before exam. – Enalapril maleate (Vasotec® intravenous over 3–5 minutes).
  • 4.
    Indications • Evaluation forrenal artery stenosis, obstruction, and/or trauma. • Evaluation of renal tubular function and perfusion (glomerular filtration) for blood flow, parenchyma, and excretion. • Evaluation of renal vascular flow (effective renal plasma flow). • Evaluation of renal obstructive nephropathy and/or hydronephrosis (study with furosemide).
  • 5.
    Indications • Evaluation forrenal (renovascular) hypertension (captopril study). • Evaluation of renovascular hypertension therapy. • Evaluation of abdominal or flank bruits, azotemia, pulmonary edema, retinopathy, and unexplained renal dysfunction. • Detection of acute tubular necrosis. • Evaluation of a kidney transplant.
  • 6.
    Contraindications • Iodine IVcontrast study on same day. • Patient still on adrenal cortical extract (ACE, or angiotensin-converting enzyme) inhibitors or angiotensin receptor blocker (ARB). • Food intake too close to a captopril study will decrease the sensitivity of the test and slow the absorption of the ACE inhibitor. • Beta blockers may affect production of renin.
  • 7.
    Patient Preparation • Identifythe patient. Verify doctor's order. Explain the procedure. • Instruct patient to hydrate well (water) and void just before test. • Physician is to instruct patient to discontinue ACE inhibitors for several days (3–7) before examination. • Instruct patient to be NPO for at least four hours on morning before captopril study. • Post study voiding is recommended to lessen bladder exposure.
  • 8.
    Equipment Camera Large field ofview Collimator low energy, all purpose, or low energy, high resolution
  • 9.
    Normal Results • Assumingtwo kidneys, both kidneys visualizing about the same size and intensities. • Excretion at the same rate. • Smooth renal contour. • Time-to-peak concentration is 3 to 5 minutes. • Clearance t1/2 is 12 to 15 minutes. • GFR (glomerular filtration rate) = 125 mL/minute.
  • 10.
    Artifacts • Some patientsdo not have both kidneys. • Injection problems for flow or bad start. • Infiltration at the injection site can alter renography curves, food within 4 hours of study, pelvic retention, dehydration, hypotension, or full bladder at the start of the study. • False-positives of mechanical obstruction: poor hydration.
  • 11.
    Patient History 1(The patient should answer the following questions). • Do you have a history of kidney disease (e.g., stones, infections)? • Do you have both kidneys? • Are there any recent or planned operations? • Do you have any renal pain? • Are you experiencing urinary frequency or urgency?
  • 12.
    Patient History 2(The patient should answer the following questions). • Do you have any blood in your urine? • Do you have high blood pressure? • Do you have the results of any recent renal laboratory tests? • What medications are you currently taking (please list)? • Female: Are you pregnant or nursing?